LivaNova PLC (LIVN) Issues Earnings Results
LivaNova PLC (NASDAQ:LIVN) announced its earnings results on Thursday. The company reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.76 by $0.17, Bloomberg Earnings reports. The business had revenue of $309.70 million during the quarter, compared to analyst estimates of $301.22 million. LivaNova PLC had a net margin of 2.26% and a return on equity of 9.08%. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.78 EPS. LivaNova PLC updated its FY17 guidance to $3.30-3.45 EPS.
In related news, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction on Monday, October 16th. The shares were sold at an average price of $74.58, for a total transaction of $74,580.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders have sold 3,000 shares of company stock valued at $203,890 over the last 90 days. 0.28% of the stock is currently owned by insiders.
Several equities research analysts have recently commented on the company. Canaccord Genuity restated a “hold” rating and issued a $71.00 price objective on shares of LivaNova PLC in a research note on Wednesday, September 20th. Jefferies Group LLC upped their price objective on LivaNova PLC from $76.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, September 15th. Needham & Company LLC upgraded LivaNova PLC from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research note on Friday, September 15th. Piper Jaffray Companies restated an “overweight” rating and issued a $75.00 price objective on shares of LivaNova PLC in a research note on Tuesday, September 12th. Finally, WBB Securities lowered LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price objective for the company. in a research note on Tuesday, August 15th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $71.50.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.